Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 110,000 shares at $16.69 ($1.8M) on 2025-03-20, disclosed to the SEC on 2025-03-21.
Scheduled sale ($1.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.69 | 55,000 | $918K | 50.0% |
| 2 | $16.69 | 55,000 | $918K | 50.0% |
| Total | $16.69 avg | 110,000 | $1.8M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CLVT | BUY | 2025-03-05 | $508K | — | Filing → |